We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Doctors Group Urges Indian Generics Makers to Reject Hep C Licensing Deal
Doctors Group Urges Indian Generics Makers to Reject Hep C Licensing Deal
Médecins Sans Frontières is urging Indian generics makers to reject a program Gilead plans to implement in developing countries to prevent illegal diversion of its hepatitis C drugs to more lucrative markets.